
Overview
As a blood cancer specialist and also a palliative care physician, I bring a different focus to cancer care. I’m working hard to improve the treatment experience for patients who are living with blood cancers. By understanding your experience better, we can develop new ways to improve your quality of life, and provide additional support throughout your treatment and beyond.
Dr. Leblanc is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration.
Dr. Leblanc is board certified in American Board Of Internal Med, Hospice & Palliative Medicine and American Board Of Internal Med, Medical Oncology. He is actively involved in clinical research, co-authoring 276 peer reviewed articles and participating in 2 clinical trials. Dr. Leblanc is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2400 Pratt St, Durham, NC 27705
20 Duke Medicine Cir, Durham, NC 27710
Additional Areas of Focus
Dr. Leblanc has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Duke Cancer Center
I am a medical oncologist who focuses on bone and soft tissue cancers called sarcomas. I love spending time with my patients. They often have a sense of awareness about their condition that’s truly unique and rewarding. I partner with each patient so they know the full set of options available for treatment and can make an informed decision about the approach that is best for them. I’ve wanted to pursue medicine for as long as I can remember. I find cancer fascinating because of its ability to evade the immune system. The body fails to recognize cancer as being foreign. When I am not at work, I love spending time with my family and enjoy long distance running. Dr. Riedel is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Desmoid Tumor, and Angiosarcoma. Dr. Riedel is board certified in American Board Of Internal Med, Internal Medicine and American Board Of Internal Med, Medical Oncology. Dr. Riedel is currently accepting new patients.
Duke Cancer Center Brain Tumor Clinic
I am an academic adult and pediatric neuro-oncologist who helps lead The Preston Robert Tisch Brain Tumor Center at Duke. I am the author of more than 500 peer-reviewed articles, reviews, and book chapters, and I have presented extensively at both international and national meetings. I am a committed educator who is a member of the executive and super-executive committees of the Duke University School of Medicine, which are responsible for the recruitment, screening and selection of medical students. I have reviewed grants for the National Institutes of Health for over 15 years, in a spectrum of different study sections. I am the senior editor of CNS Oncology and a reviewer for over 25 academic journals. I serve on the advisory board of a number of organizations, including Voices Against Brain Cancer, the Tug McGraw Foundation, Pinnacle Care, the Pediatric Brain Tumor Foundation, the National Children’s Cancer Society, and the American Brain Tumor Association. Dr. Friedman is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Glioma, Astrocytoma, Glioblastoma, and Brain Tumor. Dr. Friedman is board certified in American Board Of Pediatrics, General Pediatrics and American Board Of Pediatrics, Pediatric Hematology-Oncology. Dr. Friedman is currently accepting new patients.
Duke Blood Cancer Center
I entered medical school for the sole purpose of learning more about human diseases, so that I could focus my laboratory efforts on improving the human condition. However, I was surprised to find myself drawn to clinical care. I care for people afflicted by acute leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. In this role, I have had the privilege of treating people facing life-threatening illnesses. I strive to gain the trust of each of my patients, so that I can help them make difficult treatment decisions. I engage in clinical research, evaluating novel agents that directly target the cancer cell to improve the degree of success in treating this illness. My patients benefit from my understanding of the newest available treatments, and also have access to promising investigational agents, when appropriate. In my faculty position at Duke University, I enjoy educating current oncologists as well as the next generation of physicians. Dr. Erba is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Erba is board certified in American Board Of Internal Med, Hematology. Dr. Erba is currently accepting new patients.
Duke Cancer Center Genitourinary (GU) Clinic
I specialize in the care of patients with urologic cancers – mainly prostate cancer, kidney cancer, bladder cancer and testicular cancer. A cancer diagnosis is one of the scariest things that can happen to someone. For many of our patients, they don’t necessarily feel different or look different, but they are scared to death. The most important thing you can get from Duke is real understanding of your particular case and what your options are. Knowledge is so reassuring and empowering for patients, especially those recently diagnosed with cancer. When you’re first diagnosed, you have to put your trust in a care team, and that’s hard to do if you don’t already know them. As the largest cancer center in North Carolina, Duke has great reputation and experience, which helps many patients chose Duke for their care. But we grow and develop our trust with patients because of who we are as people and how much expertise and care we bring to each case. Dr. George is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Nephrectomy, and Orchiectomy. Dr. George is currently accepting new patients.
Duke University Health System Inc
Danielle Brander is an Oncologist practicing medicine in Durham, North Carolina. Dr. Brander is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Leukemia, and Bone Marrow Aspiration. Dr. Brander is currently accepting new patients.
Duke Cancer Center
Diane Reidy-Lagunes is a Hematologist Oncology specialist and a Hematologist practicing medicine in Durham, North Carolina. Dr. Reidy-Lagunes is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatic Cancer, Liver Embolization, and Pancreaticoduodenectomy. Dr. Reidy-Lagunes is currently accepting new patients.
Frequently Asked Questions about Dr. Thomas W. Leblanc
How do I make an appointment with Dr. Thomas W. Leblanc?
You can book an appointment with Dr. Thomas W. Leblanc by calling their office at 919-684-8964. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Thomas W. Leblanc a top-rated expert for Acute Myeloid Leukemia (AML)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Thomas W. Leblanc is classified as an Elite expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Thomas W. Leblanc specialize in?
While Dr. Thomas W. Leblanc is a Oncology, they have specific expertise in Acute Myeloid Leukemia (AML), Leukemia, and Acute Myeloblastic Leukemia without Maturation. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Thomas W. Leblanc participate in research or clinical trials?
Yes. Dr. Thomas W. Leblanc has published 276 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Dr. Thomas W. Leblanc's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Thomas W. Leblanc accept my insurance?
Dr. Thomas W. Leblanc accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 919-684-8964 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Acute Myeloid Leukemia (AML)Dr. Leblanc isElite. Learn about Acute Myeloid Leukemia (AML).
- Distinguished
- Acute Myeloblastic Leukemia without Maturation
- LeukemiaDr. Leblanc isDistinguished. Learn about Leukemia.
- Myelodysplastic Syndrome (MDS)Dr. Leblanc isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Bone Marrow AspirationDr. Leblanc isAdvanced. Learn about Bone Marrow Aspiration.
- Bone Marrow TransplantDr. Leblanc isAdvanced. Learn about Bone Marrow Transplant.
- Childhood Acute Myeloid LeukemiaDr. Leblanc isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic Myelogenous Leukemia (CML)Dr. Leblanc isAdvanced. Learn about Chronic Myelogenous Leukemia (CML).
- Mantle Cell Lymphoma (MCL)Dr. Leblanc isAdvanced. Learn about Mantle Cell Lymphoma (MCL).
- Multiple MyelomaDr. Leblanc isAdvanced. Learn about Multiple Myeloma.
- Non-Hodgkin LymphomaDr. Leblanc isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Philadelphia-Negative Chronic Myeloid Leukemia
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Leblanc isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Promyelocytic LeukemiaDr. Leblanc isExperienced. Learn about Acute Promyelocytic Leukemia.
- AgranulocytosisDr. Leblanc isExperienced. Learn about Agranulocytosis.
- AnemiaDr. Leblanc isExperienced. Learn about Anemia.
- Aplastic AnemiaDr. Leblanc isExperienced. Learn about Aplastic Anemia.
- B-Cell LymphomaDr. Leblanc isExperienced. Learn about B-Cell Lymphoma.
- Breast CancerDr. Leblanc isExperienced. Learn about Breast Cancer.
- Castleman DiseaseDr. Leblanc isExperienced. Learn about Castleman Disease.
- Chronic B-Cell Leukemia (CBCL)Dr. Leblanc isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Familial NeutropeniaDr. Leblanc isExperienced. Learn about Chronic Familial Neutropenia.
- Chronic Lymphocytic Leukemia (CLL)Dr. Leblanc isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Chronic Myelomonocytic Leukemia (CMML)Dr. Leblanc isExperienced. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Leblanc isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Febrile NeutropeniaDr. Leblanc isExperienced. Learn about Febrile Neutropenia.
- Hodgkin LymphomaDr. Leblanc isExperienced. Learn about Hodgkin Lymphoma.
- Large-Cell Immunoblastic LymphomaDr. Leblanc isExperienced. Learn about Large-Cell Immunoblastic Lymphoma.
- Lung CancerDr. Leblanc isExperienced. Learn about Lung Cancer.
- Marginal Zone Lymphoma (MZL)Dr. Leblanc isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- Multicentric Castleman Disease (MCD)Dr. Leblanc isExperienced. Learn about Multicentric Castleman Disease (MCD).
- MyelofibrosisDr. Leblanc isExperienced. Learn about Myelofibrosis.
- Myeloproliferative Neoplasms (MPN)Dr. Leblanc isExperienced. Learn about Myeloproliferative Neoplasms (MPN).
- Non-Small Cell Lung Cancer (NSCLC)Dr. Leblanc isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Peripheral T-Cell LymphomaDr. Leblanc isExperienced. Learn about Peripheral T-Cell Lymphoma.
- Polycythemia VeraDr. Leblanc isExperienced. Learn about Polycythemia Vera.
- Prolymphocytic LeukemiaDr. Leblanc isExperienced. Learn about Prolymphocytic Leukemia.
- Relapsed Refractory Multiple Myeloma (RRMM)
- Richter SyndromeDr. Leblanc isExperienced. Learn about Richter Syndrome.
- Smoldering Multiple MyelomaDr. Leblanc isExperienced. Learn about Smoldering Multiple Myeloma.
- T-Cell LymphomaDr. Leblanc isExperienced. Learn about T-Cell Lymphoma.
- Unicentric Castleman Disease (UCD)Dr. Leblanc isExperienced. Learn about Unicentric Castleman Disease (UCD).
- Venous Thromboembolism (VTE)Dr. Leblanc isExperienced. Learn about Venous Thromboembolism (VTE).




